Launchcyte is a Pittsburgh-based company specializing in the development of predictive, biological models for drug targets and clinical trials. Their model simulations provide valuable insights for clients throughout the drug development process, including pre-clinical targeting, trial designs, combination drug synergies, and FDA requests.
Immunetrics, a division of Launchcyte, offers a range of modeling services such as clinical trial simulations, trial optimization, bioequivalence analysis, and parameter estimation. Their Thales Model Development Platform and disease-specific models enable the evaluation of novel targets and compounds, opening up new opportunities and revolutionizing the approach to drug development.
Generated from the website